Sale disclosed
Ourania Tatsis
EVP, Chief Reg. & Quality Off.
Common Stock
- Reported value
- $787.49K
- Reported price
- $524.99 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
VERTEX PHARMACEUTICALS INC / MA
Last 30 daysNo qualifying insider buying. No qualifying insider sales.
Showing the first 6 of 16 trades on this page.
EVP, Chief Reg. & Quality Off.
Common Stock
EVP, Chief Commercial Officer
Common Stock
No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
EVP and Chief Legal Officer
Common Stock
EVP and CMO
Common Stock
EVP and CMO
Common Stock
EVP and CMO
Common Stock
EVP and CMO
Common Stock
EVP and Chief Legal Officer
Common Stock
EVP and CMO
Common Stock
EVP, Chief Scientific Officer
Common Stock
EVP and CMO
Common Stock
EVP and CMO
Common Stock
EVP and Chief Legal Officer
Common Stock
Director
Common Stock
EVP and Chief Legal Officer
Common Stock
EVP and CMO
Common Stock
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| EVP, Chief Reg. & Quality Off. | Common StockSale10b5-1 | 1,500$524.99 / share | $787.49K | Jul 2Filed Jul 7 · 5d later | SEC filing |
| EVP, Chief Commercial Officer | Common StockSale10b5-1 | 1,541$519.00 / share | $799.78K | Jul 2Filed Jul 7 · 5d later | SEC filing |
| EVP and Chief Legal Officer | Common StockSale10b5-1 | 828$502.71 / share | $416.24K | Jul 1Filed Jul 6 · 5d later | SEC filing |
| EVP and CMO | Common StockSale10b5-1 | 596$482.50 / share | $287.57K | Jun 26Filed Jun 30 · 4d later | SEC filing |
| EVP and CMO | Common StockSale10b5-1 | 1,020$462.17 / share | $471.41K | Jun 18Filed Jun 23 · 5d later | SEC filing |
| EVP and CMO | Common StockSale10b5-1 | 4,062$450.00 / share | $1.83M | Jun 15Filed Jun 17 · 2d later | SEC filing |
| EVP and CMO | Common StockSale10b5-1 | 1,745$450.00 / share | $785.25K | Jun 5Filed Jun 9 · 4d later | SEC filing |
| EVP and Chief Legal Officer | Common StockSale10b5-1 | 828$439.91 / share | $364.25K | Jun 1Filed Jun 3 · 2d later | SEC filing |
| EVP and CMO | Common StockSale10b5-1 | 1,974$450.00 / share | $888.3K | May 29Filed Jun 2 · 4d later | SEC filing |
| EVP, Chief Scientific Officer | Common StockSale10b5-1 | 33$453.45 / share | $14.96K | May 15Filed May 19 · 4d later | SEC filing |
| EVP and CMO | Common StockSale10b5-1 | 1,354$453.45 / share | $613.97K | May 15Filed May 19 · 4d later | SEC filing |
| EVP and CMO | Common StockSale10b5-1 | 6,988$450.00 / share | $3.14M | May 12Filed May 14 · 2d later | SEC filing |
| EVP and Chief Legal Officer | Common StockSale10b5-1 | 1,104$425.02 / share | $469.22K | May 1Filed May 5 · 4d later | SEC filing |
| Director | Common StockSale10b5-1 | 318$423.73 / share | $134.75K | May 4Filed May 5 · 1d later | SEC filing |
| EVP and Chief Legal Officer | Common StockSale10b5-1 | 978$449.17 / share | $439.29K | Apr 1Filed Apr 3 · 2d later | SEC filing |
| EVP and CMO | Common StockSale10b5-1 | 2,329$450.95 / share | $1.05M | Mar 27Filed Mar 31 · 4d later | SEC filing |
Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) · Stock
The filing reports a sale for the member.
David J. TaylorReporting House memberVertex Pharmaceuticals Incorporated - Common Stock · Stock
The filing reports a full sale for a joint account.
Thomas H TubervilleReporting Senate memberVertex Pharmaceuticals Incorporated - Common Stock · Stock
The filing reports a purchase for the member.
Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) · Stock
The filing reports a sale for the member.
David J. TaylorReporting House memberVertex Pharmaceuticals Incorporated - Common Stock (VRTX) · Stock
The filing reports a purchase for the member.
Julia LetlowReporting House member